CNC - Centene Corporation
NEXT EARNINGS:
Apr 24, 2026
EPS Est: $1.93
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$45.10
DETAILS
HIGH:
$59.00
LOW:
$38.00
MEDIAN:
$44.50
CONSENSUS:
$45.10
UPSIDE:
6.44%
Market Cap:
20.84B
Volume:
4,959,137
Avg Volume:
6,540,045
52 Week Range:
25.08-66.03
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Beta:
0.49
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
60,400
IPO Date:
2001-12-13
EPS (TTM):
-13.61
P/E Ratio:
-3.03
Revenue (TTM):
194.78B
Total Assets:
77.66B
Total Debt:
18.78B
Cash & Equiv:
17.89B
Rev Growth (5Y):
11.9%
EPS Growth (5Y):
14.7%
FCF Growth (5Y):
-1.4%
ROCE:
-11.4%
Debt/Equity:
0.94
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-06 | $-1.19 | $-1.22 | +2.5% | $49.7B | $48.4B | +2.7% |
| 2025-10-29 | $0.50 | $-0.14 | +445.4% | $49.7B | $47.7B | +4.1% |
| 2025-07-25 | $-0.16 | $0.11 | -243.4% | $48.7B | $44.1B | +10.4% |
| 2025-04-25 | $2.90 | $2.52 | +15.1% | $46.6B | $42.8B | +9.0% |
| 2025-02-04 | $0.80 | $0.44 | +81.8% | $40.8B | $39.4B | +3.7% |
| 2024-10-25 | $1.62 | $1.33 | +21.8% | $42.0B | $37.9B | +10.8% |
| 2024-07-26 | $2.42 | $2.07 | +16.9% | $39.8B | $36.8B | +8.2% |
| 2024-04-26 | $2.26 | $2.08 | +8.7% | $40.4B | $36.4B | +10.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 194.78B | 163.07B | 154.00B | 144.55B | 125.98B | 111.11B | 74.64B | 60.12B | 48.38B | 40.61B | 22.76B | 16.56B |
| Net Income | (6.67B) | 3.31B | 2.70B | 1.20B | 1.35B | 1.81B | 1.32B | 900.00M | 828.00M | 562.00M | 355.00M | 271.00M |
| EPS | -13.61 | 6.33 | 4.97 | 2.09 | 2.31 | 3.17 | 3.19 | 2.31 | 2.40 | 1.76 | 1.49 | 1.17 |
| Total Assets | 77.66B | 82.44B | 84.64B | 76.87B | 78.38B | 68.72B | 40.99B | 30.90B | 21.86B | 20.20B | 7.34B | 5.84B |
| Total Debt | 18.78B | 19.43B | 18.88B | 21.33B | 22.66B | 18.32B | 14.51B | 6.69B | 4.70B | 4.66B | 1.22B | 879.00M |
| Cash & Equivalents | 17.89B | 14.06B | 17.19B | 12.07B | 13.12B | 10.80B | 12.12B | 5.34B | 4.07B | 3.93B | 1.76B | 1.61B |
| Operating Cash Flow | 5.09B | 154.00M | 8.05B | 6.26B | 4.21B | 5.50B | 1.48B | 1.23B | 1.49B | 1.85B | 658.00M | 1.22B |
| Free Cash Flow | 4.32B | (490.00M) | 7.25B | 5.26B | 3.29B | 4.63B | 753.00M | 559.00M | 1.07B | 1.54B | 508.00M | 1.12B |
| FCF per Share | 8.80 | -0.94 | 13.35 | 9.14 | 5.65 | 8.12 | 1.82 | 1.43 | 3.09 | 4.84 | 2.13 | 4.81 |
| Book Value | 19.95B | 26.41B | 25.84B | 24.06B | 26.80B | 25.77B | 12.55B | 10.92B | 6.85B | 5.89B | 2.16B | 1.74B |
| Cash & ST Investments | 17.89B | 16.68B | 19.65B | 14.39B | 14.66B | 12.38B | 12.99B | 6.06B | 4.60B | 4.43B | 1.94B | 1.79B |
| ROC Equity | -0.33 | 0.13 | 0.10 | 0.05 | 0.05 | 0.07 | 0.11 | 0.08 | 0.12 | 0.10 | 0.16 | 0.16 |